Cellceutix continues to gain industry attention by both investors, big pharma and publications. Their Chief Executive Officer was featured on the front page of Friday's Boston Business Journal. As the clinical trials for Kevetrin should be starting in a couple months at Dana-Farber, attention should continue to increase.

BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) today announced that BioSante will present at three healthcare conferences in September.

Biotech/Medical Technology Stock News; Aethlon Medical (OTCBB: AEMD) Announces Sarcoma, Lung Cancer, Prostate Cancer, Metastatic Melanoma, and Head and Neck Cancer Studies

OSI Systems, Inc. (Nasdaq:OSIS) announced that its Security division, Rapiscan Systems, was awarded a multimillion dollar contract from an Eastern European customer in its Eagle cargo and vehicle inspection product line.

There is an ongoing shift in trend towards personalized medicine. While this offers significant advantages over classic treatment standards, it also opens a window of opportunity for drug makers and device manufacturers to generate revenue streams.

Stock-PR Reporting

FREE Daily Stock Alerts From Stock-PR.com

________________________________________